Publications
- Myxovirus Resistance Protein A mRNA Expression Kinetics in Multiple Sclerosis Patients Treated with IFN beta2017 | First Faculty of Medicine, Second Faculty of Medicine
- High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience2010 | First Faculty of Medicine, Third Faculty of Medicine
- Peripheral blood mononuclear cell phenotyping in multiple sclerosis patients-different effects of cyclophosphamide and new promising drug natalizumabPublication without faculty affiliation
- CD4+ T-cells counts and TH1/Th2 cytokine production after natalizumab treatment in multiple sclerosis patientsPublication without faculty affiliation
- Missed diagnosis of Fabry disease: should we screen patients with multiple sclerosis?2024 | First Faculty of Medicine
- Multiple Sclerosis and Microbiome2022 | First Faculty of Medicine, Faculty of Physical Education and Sport
- To be or not to be vaccinated: The risk of MS or NMOSD relapse after COVID-19 vaccination and infection2022 | First Faculty of Medicine
- Long-term management of oral cladribine treatment in multiple sclerosis2021 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Pregnancy and multiple sclerosis from a neurologist's point of view2018 | First Faculty of Medicine, Second Faculty of Medicine
- Komentář: Post hoc analýza studie CLARITY - účinnost perorálně podávaného kladribinu u pacientů s vysokou aktivitou relabující-remitující RS2018 | First Faculty of Medicine
Loading network view...